

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 5.65820395 |
| 2 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 5.62524629 |
| 3 | ribonucleoprotein complex disassembly (GO:0032988) | 5.58128128 |
| 4 | regulation of sarcomere organization (GO:0060297) | 5.25018724 |
| 5 | formation of translation preinitiation complex (GO:0001731) | 5.08028660 |
| 6 | organelle disassembly (GO:1903008) | 5.07096142 |
| 7 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.03277282 |
| 8 | cullin deneddylation (GO:0010388) | 5.00325674 |
| 9 | negative regulation of protein localization to cell surface (GO:2000009) | 4.94210422 |
| 10 | membrane raft organization (GO:0031579) | 4.84129334 |
| 11 | proteasome assembly (GO:0043248) | 4.77493394 |
| 12 | protein deneddylation (GO:0000338) | 4.74051063 |
| 13 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.61864106 |
| 14 | nucleobase biosynthetic process (GO:0046112) | 4.55607871 |
| 15 | DNA deamination (GO:0045006) | 4.54644575 |
| 16 | purine nucleobase biosynthetic process (GO:0009113) | 4.54074213 |
| 17 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.52410562 |
| 18 | plasma membrane repair (GO:0001778) | 4.51719037 |
| 19 | establishment of integrated proviral latency (GO:0075713) | 4.41338389 |
| 20 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.39114208 |
| 21 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 4.36268182 |
| 22 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 4.33295017 |
| 23 | negative regulation of heart growth (GO:0061117) | 4.33295017 |
| 24 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.30833678 |
| 25 | negative regulation of organelle assembly (GO:1902116) | 4.26720532 |
| 26 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.23588869 |
| 27 | maturation of SSU-rRNA (GO:0030490) | 4.21928703 |
| 28 | regulation of skeletal muscle contraction (GO:0014819) | 4.21162468 |
| 29 | negative regulation of muscle hypertrophy (GO:0014741) | 4.20417614 |
| 30 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.20387331 |
| 31 | negative regulation of ligase activity (GO:0051352) | 4.20278398 |
| 32 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.20278398 |
| 33 | ribosome assembly (GO:0042255) | 4.17545374 |
| 34 | ribosomal small subunit assembly (GO:0000028) | 4.08287761 |
| 35 | DNA strand elongation (GO:0022616) | 4.04475500 |
| 36 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.00834015 |
| 37 | ATP synthesis coupled proton transport (GO:0015986) | 3.93936337 |
| 38 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.93936337 |
| 39 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.92501694 |
| 40 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.91490149 |
| 41 | ribosome biogenesis (GO:0042254) | 3.88700711 |
| 42 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.86616966 |
| 43 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.85711382 |
| 44 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.85711382 |
| 45 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.83758333 |
| 46 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.83743633 |
| 47 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.83743633 |
| 48 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.83743633 |
| 49 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.82892900 |
| 50 | DNA replication checkpoint (GO:0000076) | 3.81701150 |
| 51 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.79236705 |
| 52 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.79236705 |
| 53 | spliceosomal snRNP assembly (GO:0000387) | 3.78728828 |
| 54 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.75561309 |
| 55 | IMP biosynthetic process (GO:0006188) | 3.72966297 |
| 56 | positive regulation of ligase activity (GO:0051351) | 3.69590098 |
| 57 | histone arginine methylation (GO:0034969) | 3.67492458 |
| 58 | establishment of viral latency (GO:0019043) | 3.58164429 |
| 59 | telomere maintenance via recombination (GO:0000722) | 3.57008152 |
| 60 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.47700176 |
| 61 | DNA ligation (GO:0006266) | 3.47409063 |
| 62 | regulation of spindle organization (GO:0090224) | 3.47193155 |
| 63 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.46639568 |
| 64 | negative regulation of monooxygenase activity (GO:0032769) | 3.45260986 |
| 65 | DNA replication initiation (GO:0006270) | 3.44724718 |
| 66 | protein neddylation (GO:0045116) | 3.44221236 |
| 67 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 3.43407176 |
| 68 | negative regulation of cell size (GO:0045792) | 3.39361026 |
| 69 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.38246239 |
| 70 | regulation of cellular amine metabolic process (GO:0033238) | 3.36958578 |
| 71 | de novo protein folding (GO:0006458) | 3.35912701 |
| 72 | viral mRNA export from host cell nucleus (GO:0046784) | 3.35349902 |
| 73 | chaperone-mediated protein transport (GO:0072321) | 3.34203960 |
| 74 | termination of RNA polymerase III transcription (GO:0006386) | 3.33860083 |
| 75 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.33860083 |
| 76 | de novo posttranslational protein folding (GO:0051084) | 3.33485172 |
| 77 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.33175695 |
| 78 | mitotic recombination (GO:0006312) | 3.29983251 |
| 79 | peptidyl-arginine methylation (GO:0018216) | 3.29596671 |
| 80 | peptidyl-arginine N-methylation (GO:0035246) | 3.29596671 |
| 81 | regulation of ligase activity (GO:0051340) | 3.29349634 |
| 82 | negative regulation of cardiac muscle tissue development (GO:0055026) | 3.28230156 |
| 83 | rRNA modification (GO:0000154) | 3.28033460 |
| 84 | cell cycle G1/S phase transition (GO:0044843) | 3.26636515 |
| 85 | G1/S transition of mitotic cell cycle (GO:0000082) | 3.26636515 |
| 86 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.25022597 |
| 87 | positive regulation of cell cycle arrest (GO:0071158) | 3.23873822 |
| 88 | maturation of 5.8S rRNA (GO:0000460) | 3.23579884 |
| 89 | telomere maintenance via telomere lengthening (GO:0010833) | 3.22777477 |
| 90 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.21900768 |
| 91 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 3.21605998 |
| 92 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.21300848 |
| 93 | 7-methylguanosine mRNA capping (GO:0006370) | 3.20876897 |
| 94 | ribosomal large subunit biogenesis (GO:0042273) | 3.19264060 |
| 95 | mitotic metaphase plate congression (GO:0007080) | 3.19098323 |
| 96 | translational initiation (GO:0006413) | 3.16718634 |
| 97 | NADH metabolic process (GO:0006734) | 3.14111032 |
| 98 | mitotic nuclear envelope disassembly (GO:0007077) | 3.13745562 |
| 99 | pseudouridine synthesis (GO:0001522) | 3.13396236 |
| 100 | regulation of mitochondrial translation (GO:0070129) | 3.12350008 |
| 101 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.11737360 |
| 102 | negative regulation of protein ubiquitination (GO:0031397) | 3.10660423 |
| 103 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.09864377 |
| 104 | COPI coating of Golgi vesicle (GO:0048205) | 3.09825807 |
| 105 | Golgi transport vesicle coating (GO:0048200) | 3.09825807 |
| 106 | 7-methylguanosine RNA capping (GO:0009452) | 3.09677041 |
| 107 | RNA capping (GO:0036260) | 3.09677041 |
| 108 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.08444704 |
| 109 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.08292009 |
| 110 | respiratory electron transport chain (GO:0022904) | 3.07443536 |
| 111 | protein maturation by protein folding (GO:0022417) | 3.05742745 |
| 112 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.05655681 |
| 113 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.05655681 |
| 114 | oxidative phosphorylation (GO:0006119) | 3.04929870 |
| 115 | translational elongation (GO:0006414) | 3.03836070 |
| 116 | rRNA processing (GO:0006364) | 3.03581594 |
| 117 | L-methionine salvage (GO:0071267) | 3.02105690 |
| 118 | L-methionine biosynthetic process (GO:0071265) | 3.02105690 |
| 119 | amino acid salvage (GO:0043102) | 3.02105690 |
| 120 | spliceosomal complex assembly (GO:0000245) | 3.02084740 |
| 121 | electron transport chain (GO:0022900) | 3.00679603 |
| 122 | translation (GO:0006412) | 3.00530465 |
| 123 | DNA unwinding involved in DNA replication (GO:0006268) | 2.99997528 |
| 124 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.98565496 |
| 125 | viral transcription (GO:0019083) | 2.97308572 |
| 126 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.97140279 |
| 127 | mitotic sister chromatid segregation (GO:0000070) | 2.96230686 |
| 128 | IMP metabolic process (GO:0046040) | 2.95854453 |
| 129 | protein targeting to mitochondrion (GO:0006626) | 2.94672526 |
| 130 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.93317956 |
| 131 | regulation of translational termination (GO:0006449) | 2.92776063 |
| 132 | translational termination (GO:0006415) | 2.91953031 |
| 133 | rRNA metabolic process (GO:0016072) | 2.91354312 |
| 134 | nuclear envelope disassembly (GO:0051081) | 2.90950112 |
| 135 | membrane disassembly (GO:0030397) | 2.90950112 |
| 136 | amino acid activation (GO:0043038) | 2.89689104 |
| 137 | tRNA aminoacylation (GO:0043039) | 2.89689104 |
| 138 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.88111550 |
| 139 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.87347664 |
| 140 | cellular component biogenesis (GO:0044085) | 2.86950346 |
| 141 | tRNA aminoacylation for protein translation (GO:0006418) | 2.86341834 |
| 142 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.82999010 |
| 143 | negative regulation of G1/S transition of mitotic cell cycle (GO:2000134) | 2.80145954 |
| 144 | negative regulation of cell cycle G1/S phase transition (GO:1902807) | 2.80145954 |
| 145 | CENP-A containing nucleosome assembly (GO:0034080) | 2.78518046 |
| 146 | positive regulation of protein ubiquitination (GO:0031398) | 2.75592493 |
| 147 | regulation of cell cycle arrest (GO:0071156) | 2.74561847 |
| 148 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.73514138 |
| 149 | signal transduction in response to DNA damage (GO:0042770) | 2.73466035 |
| 150 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.69496871 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.47864542 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.58806291 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.16957480 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.65087441 |
| 5 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.60911625 |
| 6 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.40288455 |
| 7 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.36409910 |
| 8 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.26995696 |
| 9 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.12821698 |
| 10 | * NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.08915266 |
| 11 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.01318125 |
| 12 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.00515694 |
| 13 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.99674227 |
| 14 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.80563806 |
| 15 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.67758296 |
| 16 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.66613536 |
| 17 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.60479211 |
| 18 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.52128495 |
| 19 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.44159838 |
| 20 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.33833132 |
| 21 | * GABP_19822575_ChIP-Seq_HepG2_Human | 2.29808421 |
| 22 | VDR_22108803_ChIP-Seq_LS180_Human | 2.29093259 |
| 23 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.27107494 |
| 24 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.24906415 |
| 25 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.19976325 |
| 26 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.16164893 |
| 27 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.15077655 |
| 28 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.12933529 |
| 29 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.09936684 |
| 30 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.07261263 |
| 31 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.05259682 |
| 32 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.02535262 |
| 33 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.99562423 |
| 34 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.91380824 |
| 35 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.90244558 |
| 36 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.88536181 |
| 37 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.84726889 |
| 38 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.81800873 |
| 39 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.81157348 |
| 40 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.78619363 |
| 41 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.78617503 |
| 42 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.76847894 |
| 43 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.71930351 |
| 44 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.70808179 |
| 45 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.70324801 |
| 46 | MYC_22102868_ChIP-Seq_BL_Human | 1.66311835 |
| 47 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.63315593 |
| 48 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.62624479 |
| 49 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61661432 |
| 50 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57592520 |
| 51 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.56618659 |
| 52 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.50994556 |
| 53 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.49523078 |
| 54 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.49082292 |
| 55 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.41399434 |
| 56 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.40274178 |
| 57 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.39945401 |
| 58 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.39318438 |
| 59 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.36559625 |
| 60 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.35481898 |
| 61 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.33305533 |
| 62 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.32463195 |
| 63 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.31771231 |
| 64 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.30573862 |
| 65 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.30179805 |
| 66 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.28988199 |
| 67 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27464954 |
| 68 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.25730158 |
| 69 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.24891381 |
| 70 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.22176453 |
| 71 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.19951256 |
| 72 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.17257694 |
| 73 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.16627739 |
| 74 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.16103246 |
| 75 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.15625094 |
| 76 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.14799744 |
| 77 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.13661512 |
| 78 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.13288108 |
| 79 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.13190370 |
| 80 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.11701197 |
| 81 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.10285098 |
| 82 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.08506636 |
| 83 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.07825055 |
| 84 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.07243410 |
| 85 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05404133 |
| 86 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03655192 |
| 87 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.02916175 |
| 88 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.02611413 |
| 89 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.02355464 |
| 90 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.01977765 |
| 91 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.01900103 |
| 92 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.01718099 |
| 93 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.98507564 |
| 94 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.97969808 |
| 95 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.97662207 |
| 96 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.97478563 |
| 97 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.96511489 |
| 98 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.96359551 |
| 99 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.95596843 |
| 100 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.95440148 |
| 101 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.95206244 |
| 102 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.94358141 |
| 103 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.93593000 |
| 104 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.93140659 |
| 105 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.92769996 |
| 106 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.91118070 |
| 107 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.91033576 |
| 108 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.89575049 |
| 109 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.88741637 |
| 110 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.87233892 |
| 111 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.86745724 |
| 112 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.86491271 |
| 113 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.86165011 |
| 114 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.85775998 |
| 115 | * KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.85415155 |
| 116 | * KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.85415155 |
| 117 | * KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.85415155 |
| 118 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.80489910 |
| 119 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.78998424 |
| 120 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.76768491 |
| 121 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.74783847 |
| 122 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.73943721 |
| 123 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.72998757 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003950_abnormal_plasma_membrane | 7.41813231 |
| 2 | MP0003693_abnormal_embryo_hatching | 5.21258470 |
| 3 | MP0004957_abnormal_blastocyst_morpholog | 4.71813321 |
| 4 | MP0003111_abnormal_nucleus_morphology | 4.06650255 |
| 5 | MP0002102_abnormal_ear_morphology | 3.86989989 |
| 6 | MP0003077_abnormal_cell_cycle | 3.58197715 |
| 7 | MP0010094_abnormal_chromosome_stability | 3.57902407 |
| 8 | MP0008058_abnormal_DNA_repair | 3.08039125 |
| 9 | MP0003123_paternal_imprinting | 3.07029990 |
| 10 | MP0008007_abnormal_cellular_replicative | 3.04785835 |
| 11 | MP0008932_abnormal_embryonic_tissue | 3.04640861 |
| 12 | MP0009697_abnormal_copulation | 2.61906538 |
| 13 | MP0002653_abnormal_ependyma_morphology | 2.38314212 |
| 14 | MP0008877_abnormal_DNA_methylation | 2.29087178 |
| 15 | MP0001730_embryonic_growth_arrest | 2.21406943 |
| 16 | MP0010030_abnormal_orbit_morphology | 2.03560267 |
| 17 | MP0000350_abnormal_cell_proliferation | 1.99460140 |
| 18 | MP0001293_anophthalmia | 1.98810187 |
| 19 | MP0004272_abnormal_basement_membrane | 1.92402668 |
| 20 | MP0003786_premature_aging | 1.87400006 |
| 21 | MP0001697_abnormal_embryo_size | 1.85050011 |
| 22 | MP0003122_maternal_imprinting | 1.82535786 |
| 23 | MP0005330_cardiomyopathy | 1.81503863 |
| 24 | MP0004233_abnormal_muscle_weight | 1.77793492 |
| 25 | MP0002080_prenatal_lethality | 1.72400218 |
| 26 | MP0009333_abnormal_splenocyte_physiolog | 1.70520582 |
| 27 | MP0003646_muscle_fatigue | 1.67119826 |
| 28 | MP0001853_heart_inflammation | 1.66564254 |
| 29 | MP0002396_abnormal_hematopoietic_system | 1.64905895 |
| 30 | MP0001672_abnormal_embryogenesis/_devel | 1.55171402 |
| 31 | MP0005380_embryogenesis_phenotype | 1.55171402 |
| 32 | MP0010368_abnormal_lymphatic_system | 1.54750396 |
| 33 | MP0009780_abnormal_chondrocyte_physiolo | 1.51460748 |
| 34 | MP0000358_abnormal_cell_content/ | 1.51142233 |
| 35 | MP0003984_embryonic_growth_retardation | 1.50554754 |
| 36 | MP0004084_abnormal_cardiac_muscle | 1.47943524 |
| 37 | MP0005623_abnormal_meninges_morphology | 1.47554073 |
| 38 | MP0002088_abnormal_embryonic_growth/wei | 1.47122243 |
| 39 | MP0003119_abnormal_digestive_system | 1.45909299 |
| 40 | MP0006036_abnormal_mitochondrial_physio | 1.44480600 |
| 41 | MP0000313_abnormal_cell_death | 1.42905501 |
| 42 | MP0000490_abnormal_crypts_of | 1.41999297 |
| 43 | MP0006035_abnormal_mitochondrial_morpho | 1.39747144 |
| 44 | MP0000750_abnormal_muscle_regeneration | 1.38958060 |
| 45 | MP0005408_hypopigmentation | 1.38512221 |
| 46 | MP0000678_abnormal_parathyroid_gland | 1.36815325 |
| 47 | MP0008057_abnormal_DNA_replication | 1.34915889 |
| 48 | MP0010352_gastrointestinal_tract_polyps | 1.34771604 |
| 49 | MP0000013_abnormal_adipose_tissue | 1.34704102 |
| 50 | MP0006054_spinal_hemorrhage | 1.33413531 |
| 51 | MP0002085_abnormal_embryonic_tissue | 1.32393488 |
| 52 | MP0002160_abnormal_reproductive_system | 1.28603301 |
| 53 | MP0002019_abnormal_tumor_incidence | 1.28389165 |
| 54 | MP0003121_genomic_imprinting | 1.26270831 |
| 55 | MP0004808_abnormal_hematopoietic_stem | 1.21492765 |
| 56 | MP0002132_abnormal_respiratory_system | 1.20169791 |
| 57 | MP0002084_abnormal_developmental_patter | 1.19682148 |
| 58 | MP0004133_heterotaxia | 1.19649503 |
| 59 | MP0008872_abnormal_physiological_respon | 1.19144352 |
| 60 | MP0000858_altered_metastatic_potential | 1.18006269 |
| 61 | MP0008789_abnormal_olfactory_epithelium | 1.17772459 |
| 62 | MP0000749_muscle_degeneration | 1.16615676 |
| 63 | MP0003315_abnormal_perineum_morphology | 1.13330778 |
| 64 | MP0002938_white_spotting | 1.13052961 |
| 65 | MP0002877_abnormal_melanocyte_morpholog | 1.10536206 |
| 66 | MP0006292_abnormal_olfactory_placode | 1.09738016 |
| 67 | MP0003718_maternal_effect | 1.08754742 |
| 68 | MP0003941_abnormal_skin_development | 1.08519770 |
| 69 | MP0000372_irregular_coat_pigmentation | 1.08160244 |
| 70 | MP0009053_abnormal_anal_canal | 1.07089462 |
| 71 | MP0002751_abnormal_autonomic_nervous | 1.07036042 |
| 72 | MP0005501_abnormal_skin_physiology | 1.06138816 |
| 73 | MP0003221_abnormal_cardiomyocyte_apopto | 1.05109648 |
| 74 | MP0004197_abnormal_fetal_growth/weight/ | 1.04934005 |
| 75 | MP0001529_abnormal_vocalization | 1.04106849 |
| 76 | MP0003942_abnormal_urinary_system | 1.03861430 |
| 77 | MP0002086_abnormal_extraembryonic_tissu | 1.02111383 |
| 78 | MP0000703_abnormal_thymus_morphology | 1.01837553 |
| 79 | MP0003656_abnormal_erythrocyte_physiolo | 1.01617024 |
| 80 | MP0005394_taste/olfaction_phenotype | 1.01162477 |
| 81 | MP0005499_abnormal_olfactory_system | 1.01162477 |
| 82 | MP0002269_muscular_atrophy | 0.98293722 |
| 83 | MP0001545_abnormal_hematopoietic_system | 0.95563763 |
| 84 | MP0005397_hematopoietic_system_phenotyp | 0.95563763 |
| 85 | MP0003763_abnormal_thymus_physiology | 0.95223302 |
| 86 | MP0003806_abnormal_nucleotide_metabolis | 0.94378235 |
| 87 | MP0003567_abnormal_fetal_cardiomyocyte | 0.92910853 |
| 88 | MP0009672_abnormal_birth_weight | 0.90338992 |
| 89 | MP0000647_abnormal_sebaceous_gland | 0.88616494 |
| 90 | MP0003186_abnormal_redox_activity | 0.87874793 |
| 91 | MP0002722_abnormal_immune_system | 0.86749878 |
| 92 | MP0001542_abnormal_bone_strength | 0.86599404 |
| 93 | MP0008775_abnormal_heart_ventricle | 0.86504662 |
| 94 | MP0005395_other_phenotype | 0.86434611 |
| 95 | MP0004036_abnormal_muscle_relaxation | 0.86388224 |
| 96 | MP0000467_abnormal_esophagus_morphology | 0.85995455 |
| 97 | MP0005384_cellular_phenotype | 0.85964908 |
| 98 | MP0001986_abnormal_taste_sensitivity | 0.83263616 |
| 99 | MP0010307_abnormal_tumor_latency | 0.82408866 |
| 100 | MP0004147_increased_porphyrin_level | 0.81588472 |
| 101 | MP0001873_stomach_inflammation | 0.81339850 |
| 102 | MP0002972_abnormal_cardiac_muscle | 0.81329123 |
| 103 | MP0005083_abnormal_biliary_tract | 0.80673549 |
| 104 | MP0002398_abnormal_bone_marrow | 0.80425482 |
| 105 | MP0005360_urolithiasis | 0.79928627 |
| 106 | MP0000751_myopathy | 0.79907650 |
| 107 | MP0001764_abnormal_homeostasis | 0.79226401 |
| 108 | MP0000049_abnormal_middle_ear | 0.78900040 |
| 109 | MP0005389_reproductive_system_phenotype | 0.77931898 |
| 110 | MP0008260_abnormal_autophagy | 0.77369377 |
| 111 | MP0005084_abnormal_gallbladder_morpholo | 0.75776546 |
| 112 | MP0001919_abnormal_reproductive_system | 0.75553665 |
| 113 | MP0001661_extended_life_span | 0.74161598 |
| 114 | MP0000689_abnormal_spleen_morphology | 0.72613639 |
| 115 | MP0003890_abnormal_embryonic-extraembry | 0.72504662 |
| 116 | MP0005187_abnormal_penis_morphology | 0.71723138 |
| 117 | MP0003115_abnormal_respiratory_system | 0.71136221 |
| 118 | MP0002233_abnormal_nose_morphology | 0.70793186 |
| 119 | MP0001881_abnormal_mammary_gland | 0.70309500 |
| 120 | MP0002089_abnormal_postnatal_growth/wei | 0.70239295 |
| 121 | MP0001544_abnormal_cardiovascular_syste | 0.67638261 |
| 122 | MP0005385_cardiovascular_system_phenoty | 0.67638261 |
| 123 | MP0005621_abnormal_cell_physiology | 0.67634244 |
| 124 | MP0010630_abnormal_cardiac_muscle | 0.66085467 |
| 125 | MP0000534_abnormal_ureter_morphology | 0.66056027 |
| 126 | MP0002111_abnormal_tail_morphology | 0.65824563 |
| 127 | MP0001485_abnormal_pinna_reflex | 0.65778169 |
| 128 | MP0005023_abnormal_wound_healing | 0.65608688 |
| 129 | MP0004087_abnormal_muscle_fiber | 0.65278248 |
| 130 | MP0002210_abnormal_sex_determination | 0.63507206 |
| 131 | MP0002429_abnormal_blood_cell | 0.62987491 |
| 132 | MP0002234_abnormal_pharynx_morphology | 0.62940942 |
| 133 | MP0003385_abnormal_body_wall | 0.61953334 |
| 134 | MP0004215_abnormal_myocardial_fiber | 0.61688813 |
| 135 | MP0002106_abnormal_muscle_physiology | 0.60417289 |
| 136 | MP0003011_delayed_dark_adaptation | 0.59959533 |
| 137 | MP0000759_abnormal_skeletal_muscle | 0.59826778 |
| 138 | MP0005266_abnormal_metabolism | 0.59089395 |
| 139 | MP0002127_abnormal_cardiovascular_syste | 0.58392897 |
| 140 | MP0003787_abnormal_imprinting | 0.57982291 |
| 141 | MP0005332_abnormal_amino_acid | 0.55910795 |
| 142 | MP0001666_abnormal_nutrient_absorption | 0.55855392 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced muscle cramps (HP:0003710) | 6.04580397 |
| 2 | Calf muscle hypertrophy (HP:0008981) | 5.45848938 |
| 3 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.79830190 |
| 4 | Subaortic stenosis (HP:0001682) | 4.79830190 |
| 5 | Exercise-induced myalgia (HP:0003738) | 4.76363046 |
| 6 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.71288413 |
| 7 | Abnormality of the anterior horn cell (HP:0006802) | 4.42833333 |
| 8 | Degeneration of anterior horn cells (HP:0002398) | 4.42833333 |
| 9 | Renal cortical cysts (HP:0000803) | 3.96037136 |
| 10 | Muscle stiffness (HP:0003552) | 3.89146282 |
| 11 | Hepatocellular necrosis (HP:0001404) | 3.72993916 |
| 12 | Cerebral hypomyelination (HP:0006808) | 3.71082615 |
| 13 | Oral leukoplakia (HP:0002745) | 3.44340754 |
| 14 | Hypoplasia of the thymus (HP:0000778) | 3.40398509 |
| 15 | Birth length less than 3rd percentile (HP:0003561) | 3.39663014 |
| 16 | Hepatic necrosis (HP:0002605) | 3.26749745 |
| 17 | Sudden death (HP:0001699) | 3.24004693 |
| 18 | Aplastic anemia (HP:0001915) | 3.18554357 |
| 19 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.18005988 |
| 20 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.18005988 |
| 21 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.13211155 |
| 22 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 3.10566722 |
| 23 | Myotonia (HP:0002486) | 3.07488937 |
| 24 | Mitochondrial inheritance (HP:0001427) | 2.99304796 |
| 25 | Trismus (HP:0000211) | 2.95981674 |
| 26 | Abnormal gallbladder physiology (HP:0012438) | 2.94804908 |
| 27 | Cholecystitis (HP:0001082) | 2.94804908 |
| 28 | Acute necrotizing encephalopathy (HP:0006965) | 2.90043680 |
| 29 | Increased CSF lactate (HP:0002490) | 2.89687830 |
| 30 | Abnormal number of erythroid precursors (HP:0012131) | 2.89518778 |
| 31 | Increased serum lactate (HP:0002151) | 2.88071586 |
| 32 | Carpal bone hypoplasia (HP:0001498) | 2.84801745 |
| 33 | Rough bone trabeculation (HP:0100670) | 2.84101960 |
| 34 | Abnormality of glycolysis (HP:0004366) | 2.83904712 |
| 35 | Increased serum pyruvate (HP:0003542) | 2.83904712 |
| 36 | Amniotic constriction ring (HP:0009775) | 2.83607657 |
| 37 | Abnormality of placental membranes (HP:0011409) | 2.83607657 |
| 38 | Neck muscle weakness (HP:0000467) | 2.82414463 |
| 39 | Patellar aplasia (HP:0006443) | 2.77547146 |
| 40 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.75725325 |
| 41 | Breast hypoplasia (HP:0003187) | 2.75271321 |
| 42 | Distal lower limb muscle weakness (HP:0009053) | 2.71139503 |
| 43 | Asymmetric septal hypertrophy (HP:0001670) | 2.67187653 |
| 44 | Emotional lability (HP:0000712) | 2.63795847 |
| 45 | Abnormality of methionine metabolism (HP:0010901) | 2.63715221 |
| 46 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.62667667 |
| 47 | Unsteady gait (HP:0002317) | 2.60890852 |
| 48 | Agnosia (HP:0010524) | 2.58507764 |
| 49 | Colon cancer (HP:0003003) | 2.54670348 |
| 50 | Cerebral edema (HP:0002181) | 2.51293173 |
| 51 | Posterior subcapsular cataract (HP:0007787) | 2.50349749 |
| 52 | Abnormal cartilage morphology (HP:0002763) | 2.49678732 |
| 53 | Multiple enchondromatosis (HP:0005701) | 2.48696945 |
| 54 | Increased hepatocellular lipid droplets (HP:0006565) | 2.41122460 |
| 55 | Arterial tortuosity (HP:0005116) | 2.40659858 |
| 56 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.39279690 |
| 57 | Selective tooth agenesis (HP:0001592) | 2.39004451 |
| 58 | Reticulocytopenia (HP:0001896) | 2.37519419 |
| 59 | Reduced antithrombin III activity (HP:0001976) | 2.35175996 |
| 60 | Abnormality of the labia minora (HP:0012880) | 2.33293617 |
| 61 | Prominent metopic ridge (HP:0005487) | 2.30902520 |
| 62 | Hypoplasia of the pons (HP:0012110) | 2.28881272 |
| 63 | Renal Fanconi syndrome (HP:0001994) | 2.28055558 |
| 64 | Shoulder girdle muscle weakness (HP:0003547) | 2.25774674 |
| 65 | Abnormality of the calf musculature (HP:0001430) | 2.25587754 |
| 66 | Lactic acidosis (HP:0003128) | 2.25284741 |
| 67 | CNS demyelination (HP:0007305) | 2.22526981 |
| 68 | Exercise intolerance (HP:0003546) | 2.21427421 |
| 69 | Vascular tortuosity (HP:0004948) | 2.18920399 |
| 70 | Microretrognathia (HP:0000308) | 2.18540477 |
| 71 | Slender long bone (HP:0003100) | 2.18355263 |
| 72 | Postnatal microcephaly (HP:0005484) | 2.17649076 |
| 73 | Poor suck (HP:0002033) | 2.17374147 |
| 74 | Palpitations (HP:0001962) | 2.17252015 |
| 75 | Tongue fasciculations (HP:0001308) | 2.15237641 |
| 76 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.12808089 |
| 77 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.12237831 |
| 78 | Upper limb muscle weakness (HP:0003484) | 2.12153080 |
| 79 | Neoplasm of the pancreas (HP:0002894) | 2.11837038 |
| 80 | Neoplasm of the adrenal gland (HP:0100631) | 2.11690766 |
| 81 | Respiratory failure (HP:0002878) | 2.11099352 |
| 82 | Neuroendocrine neoplasm (HP:0100634) | 2.09656339 |
| 83 | Adenoma sebaceum (HP:0009720) | 2.09463068 |
| 84 | Angiofibromas (HP:0010615) | 2.09463068 |
| 85 | Abnormality of the metopic suture (HP:0005556) | 2.08849772 |
| 86 | Sparse eyelashes (HP:0000653) | 2.07710205 |
| 87 | Neuroblastoma (HP:0003006) | 2.07675920 |
| 88 | Primitive neuroectodermal tumor (HP:0030065) | 2.07675920 |
| 89 | Neuroblastic tumors (HP:0004376) | 2.07675920 |
| 90 | Peripheral primitive neuroectodermal neoplasm (HP:0030067) | 2.07675920 |
| 91 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.07552846 |
| 92 | Acute encephalopathy (HP:0006846) | 2.06750782 |
| 93 | Muscle fiber atrophy (HP:0100295) | 2.06551552 |
| 94 | Abnormality of the aortic arch (HP:0012303) | 2.06134742 |
| 95 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.05902520 |
| 96 | Muscle fibrillation (HP:0010546) | 2.05254635 |
| 97 | Ragged-red muscle fibers (HP:0003200) | 2.05214229 |
| 98 | Abnormality of the umbilical cord (HP:0010881) | 2.04696176 |
| 99 | Brushfield spots (HP:0001088) | 2.04654523 |
| 100 | 11 pairs of ribs (HP:0000878) | 2.04637793 |
| 101 | Poor head control (HP:0002421) | 2.03864303 |
| 102 | Premature graying of hair (HP:0002216) | 2.03325539 |
| 103 | Type I transferrin isoform profile (HP:0003642) | 2.01768895 |
| 104 | Pancytopenia (HP:0001876) | 2.01027329 |
| 105 | Lipid accumulation in hepatocytes (HP:0006561) | 2.00819759 |
| 106 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.99354284 |
| 107 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.99354284 |
| 108 | Abnormal protein glycosylation (HP:0012346) | 1.99354284 |
| 109 | Abnormal glycosylation (HP:0012345) | 1.99354284 |
| 110 | Progressive macrocephaly (HP:0004481) | 1.99058996 |
| 111 | Optic nerve coloboma (HP:0000588) | 1.98829800 |
| 112 | Absent thumb (HP:0009777) | 1.98784493 |
| 113 | Medulloblastoma (HP:0002885) | 1.98775889 |
| 114 | Secondary amenorrhea (HP:0000869) | 1.98671201 |
| 115 | Vertebral compression fractures (HP:0002953) | 1.98667874 |
| 116 | Hypoplastic pelvis (HP:0008839) | 1.97383422 |
| 117 | Progressive muscle weakness (HP:0003323) | 1.97297703 |
| 118 | Pheochromocytoma (HP:0002666) | 1.93814988 |
| 119 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.93753821 |
| 120 | Premature ovarian failure (HP:0008209) | 1.92885162 |
| 121 | Gowers sign (HP:0003391) | 1.92646443 |
| 122 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.91446693 |
| 123 | Cleft eyelid (HP:0000625) | 1.91274917 |
| 124 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.88989385 |
| 125 | Macrocytic anemia (HP:0001972) | 1.88843772 |
| 126 | Type 2 muscle fiber atrophy (HP:0003554) | 1.87809087 |
| 127 | Hepatosplenomegaly (HP:0001433) | 1.87720379 |
| 128 | Ependymoma (HP:0002888) | 1.87378794 |
| 129 | Abnormal trabecular bone morphology (HP:0100671) | 1.86193133 |
| 130 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.86016028 |
| 131 | Abnormality of alanine metabolism (HP:0010916) | 1.86016028 |
| 132 | Hyperalaninemia (HP:0003348) | 1.86016028 |
| 133 | Pelvic girdle muscle weakness (HP:0003749) | 1.85944567 |
| 134 | Abnormality of the motor neurons (HP:0002450) | 1.85465174 |
| 135 | Abnormal neuron morphology (HP:0012757) | 1.85465174 |
| 136 | Methylmalonic acidemia (HP:0002912) | 1.84481114 |
| 137 | Neoplasm of head and neck (HP:0012288) | 1.84304738 |
| 138 | Esophageal neoplasm (HP:0100751) | 1.84304738 |
| 139 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.83198812 |
| 140 | Clitoromegaly (HP:0000057) | 1.82374399 |
| 141 | 3-Methylglutaconic aciduria (HP:0003535) | 1.82136026 |
| 142 | Generalized aminoaciduria (HP:0002909) | 1.80566834 |
| 143 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.80062323 |
| 144 | Protrusio acetabuli (HP:0003179) | 1.78552317 |
| 145 | Cellular immunodeficiency (HP:0005374) | 1.77697674 |
| 146 | Lethargy (HP:0001254) | 1.76883100 |
| 147 | Delusions (HP:0000746) | 1.75781676 |
| 148 | Meckel diverticulum (HP:0002245) | 1.75236719 |
| 149 | Long palpebral fissure (HP:0000637) | 1.75230097 |
| 150 | Horseshoe kidney (HP:0000085) | 1.75081702 |
| 151 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.75057252 |
| 152 | Abnormal lung lobation (HP:0002101) | 1.74623612 |
| 153 | Abnormality of the ileum (HP:0001549) | 1.74489655 |
| 154 | Microvesicular hepatic steatosis (HP:0001414) | 1.74263451 |
| 155 | Microglossia (HP:0000171) | 1.73054061 |
| 156 | Brittle hair (HP:0002299) | 1.70677056 |
| 157 | Prolonged partial thromboplastin time (HP:0003645) | 1.68954954 |
| 158 | Leukodystrophy (HP:0002415) | 1.68725124 |
| 159 | Skin nodule (HP:0200036) | 1.65867386 |
| 160 | Palpebral edema (HP:0100540) | 1.65733838 |
| 161 | Hypoglycemic coma (HP:0001325) | 1.65670874 |
| 162 | Small epiphyses (HP:0010585) | 1.65212781 |
| 163 | Embryonal renal neoplasm (HP:0011794) | 1.64964643 |
| 164 | Abnormality of the preputium (HP:0100587) | 1.64678469 |
| 165 | Increased intramyocellular lipid droplets (HP:0012240) | 1.62673111 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.80398447 |
| 2 | EIF2AK1 | 3.93721210 |
| 3 | VRK2 | 3.65706903 |
| 4 | NEK1 | 3.40498013 |
| 5 | TSSK6 | 3.39206172 |
| 6 | MAPKAPK5 | 3.31830354 |
| 7 | TESK2 | 2.96143038 |
| 8 | MST4 | 2.95056953 |
| 9 | WEE1 | 2.65967876 |
| 10 | CCNB1 | 2.55388975 |
| 11 | STK16 | 2.52254113 |
| 12 | MUSK | 2.34077461 |
| 13 | MAP3K12 | 2.30331038 |
| 14 | SRPK1 | 2.28013571 |
| 15 | TESK1 | 2.26217064 |
| 16 | TRIM28 | 2.21277534 |
| 17 | TLK1 | 2.07399065 |
| 18 | CDC7 | 2.07356730 |
| 19 | PBK | 2.06408977 |
| 20 | PIM2 | 1.76953828 |
| 21 | NME2 | 1.73942560 |
| 22 | BRSK1 | 1.70321934 |
| 23 | DAPK1 | 1.65814451 |
| 24 | MAP3K11 | 1.58902416 |
| 25 | BRAF | 1.56912578 |
| 26 | CDK19 | 1.53952074 |
| 27 | LIMK1 | 1.49214108 |
| 28 | KDR | 1.47857322 |
| 29 | PLK4 | 1.46722707 |
| 30 | PLK1 | 1.44574489 |
| 31 | EIF2AK3 | 1.44228837 |
| 32 | DMPK | 1.42259172 |
| 33 | PLK3 | 1.39863866 |
| 34 | AKT3 | 1.39579924 |
| 35 | SIK3 | 1.37778661 |
| 36 | CASK | 1.36951068 |
| 37 | RPS6KA4 | 1.36631023 |
| 38 | BRSK2 | 1.34217384 |
| 39 | CLK1 | 1.32611786 |
| 40 | SCYL2 | 1.31563783 |
| 41 | ACVR1B | 1.30753777 |
| 42 | PAK4 | 1.26990951 |
| 43 | NUAK1 | 1.26965124 |
| 44 | NME1 | 1.24173428 |
| 45 | AURKA | 1.22166615 |
| 46 | EPHA2 | 1.18518276 |
| 47 | MYLK | 1.17886363 |
| 48 | NEK2 | 1.10757186 |
| 49 | CDK8 | 1.07781998 |
| 50 | VRK1 | 1.07412914 |
| 51 | TTK | 1.04979218 |
| 52 | TAOK2 | 1.04226401 |
| 53 | AURKB | 1.04021555 |
| 54 | TGFBR1 | 1.03743848 |
| 55 | PASK | 1.00746344 |
| 56 | EIF2AK2 | 0.98048162 |
| 57 | TRIB3 | 0.97416194 |
| 58 | CDK7 | 0.95458515 |
| 59 | CDK9 | 0.95122595 |
| 60 | DAPK3 | 0.92083104 |
| 61 | MKNK1 | 0.90360666 |
| 62 | ATR | 0.89447052 |
| 63 | ILK | 0.84333072 |
| 64 | LATS2 | 0.83367851 |
| 65 | PDK4 | 0.82543547 |
| 66 | PDK3 | 0.82543547 |
| 67 | BCR | 0.80067617 |
| 68 | PIK3CA | 0.78855618 |
| 69 | MKNK2 | 0.78133314 |
| 70 | MELK | 0.77948374 |
| 71 | ERBB4 | 0.76657434 |
| 72 | BCKDK | 0.75999374 |
| 73 | PTK2 | 0.74828629 |
| 74 | MINK1 | 0.73337495 |
| 75 | PRKCI | 0.72969313 |
| 76 | PKN2 | 0.72884112 |
| 77 | MOS | 0.71422127 |
| 78 | PAK1 | 0.71395229 |
| 79 | RPS6KB2 | 0.68813695 |
| 80 | MAP3K8 | 0.68535353 |
| 81 | PLK2 | 0.67450494 |
| 82 | TAF1 | 0.66991097 |
| 83 | ZAP70 | 0.66471083 |
| 84 | PAK2 | 0.65643294 |
| 85 | CSNK1G3 | 0.64195440 |
| 86 | MAPKAPK3 | 0.63775613 |
| 87 | MAP2K6 | 0.63075461 |
| 88 | MAP2K3 | 0.61456920 |
| 89 | CDK18 | 0.60903785 |
| 90 | CDK14 | 0.60636331 |
| 91 | LRRK2 | 0.59643406 |
| 92 | CDK11A | 0.56306680 |
| 93 | ARAF | 0.55449156 |
| 94 | MAP3K10 | 0.54770922 |
| 95 | PAK6 | 0.54391925 |
| 96 | DYRK3 | 0.52765284 |
| 97 | CDK15 | 0.52569316 |
| 98 | CSNK2A1 | 0.52146179 |
| 99 | PRPF4B | 0.51691976 |
| 100 | CSNK1A1L | 0.51399026 |
| 101 | TAOK1 | 0.49590915 |
| 102 | STK38L | 0.48877376 |
| 103 | CHEK1 | 0.48856247 |
| 104 | MAP4K1 | 0.48532247 |
| 105 | CSNK1G1 | 0.47917254 |
| 106 | ERBB3 | 0.47428930 |
| 107 | NEK9 | 0.44641570 |
| 108 | CDK2 | 0.42687397 |
| 109 | CDK4 | 0.42145755 |
| 110 | CHEK2 | 0.41794415 |
| 111 | CSNK2A2 | 0.41277713 |
| 112 | LMTK2 | 0.40648680 |
| 113 | FLT3 | 0.40505337 |
| 114 | STK4 | 0.39909665 |
| 115 | WNK4 | 0.39162601 |
| 116 | ZAK | 0.37643485 |
| 117 | ALK | 0.36723149 |
| 118 | NEK6 | 0.36330324 |
| 119 | STK3 | 0.35761267 |
| 120 | GRK5 | 0.35180213 |
| 121 | SMG1 | 0.34981199 |
| 122 | STK10 | 0.34328146 |
| 123 | FGFR1 | 0.33584663 |
| 124 | PIK3CG | 0.32872117 |
| 125 | CSNK1G2 | 0.32675868 |
| 126 | CSNK1D | 0.32675064 |
| 127 | PIM1 | 0.31819495 |
| 128 | PRKCG | 0.31327174 |
| 129 | WNK3 | 0.31105141 |
| 130 | MAP3K5 | 0.30370320 |
| 131 | PDK2 | 0.30331620 |
| 132 | PRKACB | 0.28958661 |
| 133 | DAPK2 | 0.28923146 |
| 134 | TXK | 0.28743714 |
| 135 | CSNK1E | 0.28484037 |
| 136 | ATM | 0.28404576 |
| 137 | MAP2K7 | 0.25812168 |
| 138 | CDK1 | 0.25112951 |
| 139 | PRKD3 | 0.21587912 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.88656930 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 4.17959571 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 3.52801875 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 3.36821668 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 3.22599526 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.12726478 |
| 7 | Spliceosome_Homo sapiens_hsa03040 | 3.06646193 |
| 8 | Base excision repair_Homo sapiens_hsa03410 | 2.86146048 |
| 9 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.84471122 |
| 10 | RNA transport_Homo sapiens_hsa03013 | 2.81126017 |
| 11 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.66036361 |
| 12 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.47363195 |
| 13 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.39225063 |
| 14 | Homologous recombination_Homo sapiens_hsa03440 | 2.30087545 |
| 15 | Cell cycle_Homo sapiens_hsa04110 | 2.15048000 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.80509216 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.76998126 |
| 18 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.75974008 |
| 19 | Parkinsons disease_Homo sapiens_hsa05012 | 1.74753838 |
| 20 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.69281689 |
| 21 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.67409522 |
| 22 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.63795970 |
| 23 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.45968066 |
| 24 | Purine metabolism_Homo sapiens_hsa00230 | 1.36639500 |
| 25 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.35403193 |
| 26 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.34979671 |
| 27 | Basal transcription factors_Homo sapiens_hsa03022 | 1.34081426 |
| 28 | RNA degradation_Homo sapiens_hsa03018 | 1.33640246 |
| 29 | Huntingtons disease_Homo sapiens_hsa05016 | 1.32529558 |
| 30 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.31681534 |
| 31 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.31383049 |
| 32 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.29055025 |
| 33 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.20782613 |
| 34 | Carbon metabolism_Homo sapiens_hsa01200 | 1.20490464 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.19280091 |
| 36 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.18297319 |
| 37 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.14225164 |
| 38 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.13947817 |
| 39 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.13215703 |
| 40 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.10865489 |
| 41 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.10050867 |
| 42 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.09034161 |
| 43 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.06235334 |
| 44 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.04251462 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.03884763 |
| 46 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.02689290 |
| 47 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.02356386 |
| 48 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.99742993 |
| 49 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.98399706 |
| 50 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.97001833 |
| 51 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.96238929 |
| 52 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.94403140 |
| 53 | Protein export_Homo sapiens_hsa03060 | 0.91496081 |
| 54 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.89471619 |
| 55 | Thyroid cancer_Homo sapiens_hsa05216 | 0.89418590 |
| 56 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.87398079 |
| 57 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.85622793 |
| 58 | Galactose metabolism_Homo sapiens_hsa00052 | 0.83860122 |
| 59 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.83143946 |
| 60 | Alzheimers disease_Homo sapiens_hsa05010 | 0.73336368 |
| 61 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.72334497 |
| 62 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.71206969 |
| 63 | Legionellosis_Homo sapiens_hsa05134 | 0.70772748 |
| 64 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.70098533 |
| 65 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.69305425 |
| 66 | Peroxisome_Homo sapiens_hsa04146 | 0.69003060 |
| 67 | Shigellosis_Homo sapiens_hsa05131 | 0.66949682 |
| 68 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.65166825 |
| 69 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.64298687 |
| 70 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.59870061 |
| 71 | HTLV-I infection_Homo sapiens_hsa05166 | 0.59760303 |
| 72 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.58768645 |
| 73 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.50899458 |
| 74 | Bladder cancer_Homo sapiens_hsa05219 | 0.50869691 |
| 75 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.49676564 |
| 76 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.49464535 |
| 77 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47771153 |
| 78 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.47189632 |
| 79 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.46617162 |
| 80 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.45677437 |
| 81 | Sulfur relay system_Homo sapiens_hsa04122 | 0.45550337 |
| 82 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44927547 |
| 83 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.43994891 |
| 84 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.43113359 |
| 85 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.41975719 |
| 86 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.40753852 |
| 87 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.39762940 |
| 88 | Adherens junction_Homo sapiens_hsa04520 | 0.39407570 |
| 89 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.38038579 |
| 90 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.37882800 |
| 91 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.36613866 |
| 92 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.35870623 |
| 93 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.35429072 |
| 94 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.35133585 |
| 95 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.34685312 |
| 96 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.33964663 |
| 97 | Lysine degradation_Homo sapiens_hsa00310 | 0.32782190 |
| 98 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.32602911 |
| 99 | Colorectal cancer_Homo sapiens_hsa05210 | 0.31334329 |
| 100 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.28171268 |
| 101 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.27333971 |
| 102 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.26631740 |
| 103 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.25960373 |
| 104 | Apoptosis_Homo sapiens_hsa04210 | 0.23347890 |
| 105 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.22518619 |
| 106 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.22215139 |
| 107 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.21285898 |
| 108 | Phagosome_Homo sapiens_hsa04145 | 0.21185667 |
| 109 | Metabolic pathways_Homo sapiens_hsa01100 | 0.20953427 |
| 110 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.20231326 |
| 111 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.19611120 |
| 112 | Retinol metabolism_Homo sapiens_hsa00830 | 0.19460329 |
| 113 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.17740930 |
| 114 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.15965846 |
| 115 | Melanoma_Homo sapiens_hsa05218 | 0.15493770 |
| 116 | Endocytosis_Homo sapiens_hsa04144 | 0.15061952 |
| 117 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.14820093 |
| 118 | Histidine metabolism_Homo sapiens_hsa00340 | 0.13968154 |
| 119 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.13610144 |
| 120 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.12902377 |
| 121 | Tight junction_Homo sapiens_hsa04530 | 0.12698879 |
| 122 | Influenza A_Homo sapiens_hsa05164 | 0.11022990 |
| 123 | Hepatitis B_Homo sapiens_hsa05161 | 0.10050725 |
| 124 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.09743841 |
| 125 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.09265659 |
| 126 | Viral myocarditis_Homo sapiens_hsa05416 | 0.08574814 |
| 127 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.08286327 |
| 128 | Measles_Homo sapiens_hsa05162 | 0.08094081 |
| 129 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.07706326 |
| 130 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.05278822 |
| 131 | Endometrial cancer_Homo sapiens_hsa05213 | 0.04470509 |
| 132 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.04460876 |
| 133 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.03767174 |

